ZSTK474, a specific phosphatidylinositol 3-kinase inhibitor, induces G1 arrest of the cell cycle in vivo
Authors:
- 1 April 2012
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 48 (6) , 936-943
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (22240092, 22700929)
- Ministry of Education, Culture, Sports, Science and Technology (221S0001)
This publication has 23 references indexed in Scilit:
- Advances in Development of Phosphatidylinositol 3-Kinase InhibitorsCurrent Medicinal Chemistry, 2009
- Targeting PI3K signalling in cancer: opportunities, challenges and limitationsNature Reviews Cancer, 2009
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer ModelsClinical Cancer Research, 2009
- Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitorEuropean Journal of Cancer, 2009
- Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrestBiochemical and Biophysical Research Communications, 2009
- Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase InhibitorJNCI: Journal of the National Cancer Institute, 2006
- Oncogenic Mutations of PIK3CA in Human CancersCell Cycle, 2004
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997